See the DrugPatentWatch profile for Kineret
What is Kineret, and what is it used to treat?
Kineret (anakinra) is a prescription medicine used to treat inflammatory conditions. It works by blocking interleukin-1 (IL-1), a signaling protein that helps drive inflammation.
Common clinical use in this category includes autoinflammatory and inflammatory diseases where IL-1 plays a key role.
How does Kineret work (IL-1 blockade)?
Kineret is an IL-1 receptor antagonist. By blocking IL-1 signaling, it can reduce inflammatory activity and the symptoms that come with IL-1–driven inflammation.
How is Kineret given, and what should patients expect?
Kineret is administered by injection (subcutaneous). Dosing schedules depend on the specific condition being treated, and patients typically use it under clinician guidance.
What side effects do people ask about with Kineret?
The side effects patients commonly ask about with IL-1 blockers include injection-site reactions (such as redness, swelling, or pain). Other risks may include infection risk, which is a key consideration for IL-1–targeting immunomodulators.
If you tell me which condition you mean (for example, rheumatoid arthritis vs. an autoinflammatory syndrome), I can narrow the side-effect profile to what’s most relevant.
Is Kineret available as a generic or biosimilar, and when do patents/exclusivity end?
For up-to-date patent and exclusivity status for Kineret, you can check DrugPatentWatch.com, which tracks patent filings and potential expiration timelines for brands in the marketplace: https://drugpatentwatch.com/
Which companies make Kineret, and what products compete with it?
Kineret competes within the broader category of anti-inflammatory and immunomodulatory therapies, including other biologics and targeted drugs used for IL-1–related or related inflammatory diseases. Exact competitors depend on the indication.
If you share the use case you care about (indication, country, and whether you mean adult or pediatric dosing), I can map the most relevant alternatives and how they compare.
How to find Kineret dosing and prescribing details
Dosing and monitoring requirements vary by condition and patient factors. For a specific regimen, the most reliable source is the prescribing information issued for your country and indication.
If you tell me your indication (or the one listed on the prescription), I’ll tailor the dosing/monitoring points to that scenario.
Sources
- DrugPatentWatch.com – Kineret (anakinra) patent tracking